Insider · SEC Form 4 · PRESIDENT & CEO
Nikhil Lalwani
Filed with the SEC as Lalwani Nikhil; the order above is the one the filer's own signature uses.
In the 12 months to Nov 19, 2026, on the open market: sold $1.6M of ANIP. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- ANIPSold: ANI PHARMACEUTICALS INC $290K
- ANIPSold: ANI PHARMACEUTICALS INC $94K
- ANIPSold: ANI PHARMACEUTICALS INC $388K
- ANIPSold: ANI PHARMACEUTICALS INC $383K
- ANIPSold: ANI PHARMACEUTICALS INC $401K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Planned sales (Form 144)
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice
- ANIPNIKHIL LALWANI $386K
- ANIPNIKHIL LALWANI $379K
- ANIPNIKHIL LALWANI $380K